Literature DB >> 25277751

Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease.

Manoochehr Rasouli1, Behzad Heidari2, Mehdi Kalani3.   

Abstract

Given the inflammatory nature of Kawasaki disease (KD) and the pro-inflammatory properties of Th17, this study aimed to determine the frequency of Th17 cells and the levels of corresponding cytokines in acute phase of KD and to evaluate their alterations one and eight weeks after treatment. Th17 and the related cytokine levels were measured in 21 KD patients and 42 positive and negative controls, using flow cytometry and ELISA, respectively. Th17, IL-17, IL-22 and IL-23 were significantly higher (P<0.05) in patients compared with negative controls, but no significant differences (P>0.05) with the positive controls. Furthermore, Th17, IL-17, IL-22 and IL-23 were significantly higher in patients before treatment than those one and eight weeks after. Considering the downregulation of Th17 and its related cytokines with aspirin and intravenous immunoglobulin therapy implies the probable role of Th17 in KD pathogenesis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aspirin; IL-17; IVIg; Kawasaki disease; Th17

Mesh:

Substances:

Year:  2014        PMID: 25277751     DOI: 10.1016/j.imlet.2014.09.017

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  17 in total

1.  The Effects of IL-22 on the Inflammatory Mediator Production, Proliferation, and Barrier Function of HUVECs.

Authors:  Xian He; Hui Li; Ying Chen; Aijun Chen; Kui Shan; Jin Chen; Hengguang Zhao; Xiaojiao Zhang; Tao Cai
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

2.  Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.

Authors:  Feifei Si; Yao Wu; Fang Gao; Siqi Feng; Ruixi Liu; Qijian Yi
Journal:  Clin Exp Med       Date:  2017-01-20       Impact factor: 3.984

3.  Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki disease.

Authors:  Sho Hokibara; Norimoto Kobayashi; Keiko Kobayashi; Tomonari Shigemura; Haruo Nagumo; Masahiro Takizawa; Takashi Yamazaki; Kazunaga Agematsu
Journal:  Inflamm Res       Date:  2016-03-28       Impact factor: 4.575

Review 4.  Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.

Authors:  Angela S W Tjon; Rogier van Gent; Teunis B Geijtenbeek; Jaap Kwekkeboom
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

5.  Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease.

Authors:  Wei Zhang; Yan Wang; Yiwen Zeng; Liyi Hu; Guotao Zou
Journal:  Biomed Res Int       Date:  2017-06-01       Impact factor: 3.411

6.  Atypical desquamation in a 2.5-year-old boy with Kawasaki disease: A case report.

Authors:  Ali Adib; Ali Fazel; Seyed Hesamedin Nabavizadeh; Sohaila Alyasin; Sara Kashef
Journal:  Electron Physician       Date:  2017-02-25

Review 7.  Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

Authors:  Alessandra Marchesi; Isabella Tarissi de Jacobis; Donato Rigante; Alessandro Rimini; Walter Malorni; Giovanni Corsello; Grazia Bossi; Sabrina Buonuomo; Fabio Cardinale; Elisabetta Cortis; Fabrizio De Benedetti; Andrea De Zorzi; Marzia Duse; Domenico Del Principe; Rosa Maria Dellepiane; Livio D'Isanto; Maya El Hachem; Susanna Esposito; Fernanda Falcini; Ugo Giordano; Maria Cristina Maggio; Savina Mannarino; Gianluigi Marseglia; Silvana Martino; Giulia Marucci; Rossella Massaro; Christian Pescosolido; Donatella Pietraforte; Maria Cristina Pietrogrande; Patrizia Salice; Aurelio Secinaro; Elisabetta Straface; Alberto Villani
Journal:  Ital J Pediatr       Date:  2018-08-30       Impact factor: 2.638

Review 8.  Kawasaki disease: a matter of innate immunity.

Authors:  T Hara; Y Nakashima; Y Sakai; H Nishio; Y Motomura; S Yamasaki
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

9.  Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy.

Authors:  Xiaofei Zhang; Guangda Xin; Dajun Sun
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

Review 10.  Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease.

Authors:  Caroline Galeotti; Srini V Kaveri; Rolando Cimaz; Isabelle Koné-Paut; Jagadeesh Bayry
Journal:  Drug Discov Today       Date:  2016-08-06       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.